Emerging Innovators: The Strategic Impact of Start-Up Innovation

As the pharmaceutical and biotech sectors face mounting pressure to innovate, a new wave of start-ups is emerging with disruptive technologies, agile business models, and bold scientific approaches. This panel brings together leaders at the forefront of this transformation to explore how start-ups are driving innovation across the value chain—from R&D and clinical development to manufacturing and compliance. We will examine the unique challenges these companies face in scaling, navigating regulatory environments, and engaging with larger industry stakeholders. Join us for an executive-level discussion on the strategic implications for established players and why embracing collaboration with these innovators may be key to long-term competitive advantage.